{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:03:13Z","timestamp":1791478993448,"version":"4.3.4"},"reference-count":61,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T00:00:00Z","timestamp":1521849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Co\u2010prescription of paroxetine\/fluoxetine (a strong CYP2D6 inhibitor) in metoprolol (a CYP2D6 substrate) users is common, but data on the clinical consequences of this drug\u2010drug interaction are limited and inconclusive. Therefore, we assessed the effect of paroxetine\/fluoxetine initiation on the existing treatment with metoprolol on the discontinuation and dose adjustment of metoprolol among elderly.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a cohort study using the University of Groningen IADB.nl prescription database (www.IADB.nl). We selected all elderly (\u226560\u00a0years) who had ever been prescribed metoprolol and had a first co\u2010prescription of paroxetine\/fluoxetine, citalopram (weak CYP2D6 inhibitor), or mirtazapine (negative control) from 1994 to 2015. The exposure group was metoprolol and paroxetine\/fluoxetine co\u2010prescription, and the other groups acted as controls. The outcomes were early discontinuation and dose adjustment of metoprolol. Logistic regression was applied to estimate adjusted odds ratios (OR) and 95% confidence intervals (CI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Combinations of metoprolol\u2010paroxetine\/fluoxetine, metoprolol\u2010citalopram, and metoprolol\u2010mirtazapine were started in 528, 673, and 625 patients, respectively. Compared with metoprolol\u2010citalopram, metoprolol\u2010paroxetine\/fluoxetine was not significantly associated with the early discontinuation and dose adjustment of metoprolol (OR\u00a0=\u00a01.07, 95% CI:0.77\u20101.48; OR\u00a0=\u00a00.87, 95% CI:0.57\u20101.33, respectively). In comparison with metoprolol\u2010mirtazapine, metoprolol\u2010paroxetine\/fluoxetine was associated with a significant 43% relative increase in early discontinuation of metoprolol (OR\u00a0=\u00a01.43, 95% CI:1.01\u20102.02) but no difference in the risk of dose adjustment. Stratified analysis by gender showed that women have a significantly high risk of metoprolol early discontinuation (OR\u00a0=\u00a01.62, 95% CI:1.03\u20102.53).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Paroxetine\/fluoxetine initiation in metoprolol prescriptions, especially for female older patients, is associated with the risk of early discontinuation of metoprolol.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.4422","type":"journal-article","created":{"date-parts":[[2018,3,25]],"date-time":"2018-03-25T06:32:34Z","timestamp":1521959554000},"page":"621-629","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Discontinuation and dose adjustment of metoprolol after metoprolol\u2010paroxetine\/fluoxetine co\u2010prescription in Dutch elderly"],"prefix":"10.1002","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6582-5615","authenticated-orcid":false,"given":"Muh. Akbar","family":"Bahar","sequence":"first","affiliation":[{"name":"Groningen Research Institute of Pharmacy, Department of PharmacoTherapy, \u2010Epidemiology and \u2010Economics University of Groningen  Groningen The Netherlands"},{"name":"Faculty of Pharmacy Hasanuddin University  Makassar Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Groningen Research Institute of Pharmacy, Department of PharmacoTherapy, \u2010Epidemiology and \u2010Economics University of Groningen  Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens H.J.","family":"Bos","sequence":"additional","affiliation":[{"name":"Groningen Research Institute of Pharmacy, Department of PharmacoTherapy, \u2010Epidemiology and \u2010Economics University of Groningen  Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Wilffert","sequence":"additional","affiliation":[{"name":"Groningen Research Institute of Pharmacy, Department of PharmacoTherapy, \u2010Epidemiology and \u2010Economics University of Groningen  Groningen The Netherlands"},{"name":"Department of Clinical Pharmacy and Pharmacology University Medical Center Groningen  Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelko","family":"Hak","sequence":"additional","affiliation":[{"name":"Groningen Research Institute of Pharmacy, Department of PharmacoTherapy, \u2010Epidemiology and \u2010Economics University of Groningen  Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,3,24]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2003.02040.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1R621"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12163"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2011.586337"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4200"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0404-3"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125311433580"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.104788"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.11.0143"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91265-N"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199904000-00011"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/009127000004000108"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050456"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.31.7.630"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010365559"},{"issue":"5","key":"e_1_2_8_17_1","first-page":"244","article-title":"Bradycardia after beginning therapy with metoprolol and paroxetine","volume":"23","author":"Konig F","year":"1996","journal-title":"Psychiatr Prax"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.4065\/83.5.595"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1586\/erp.13.20"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0299-3"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0436-x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1417242"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1989.tb00273.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199937050-00004"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0553-z"},{"key":"e_1_2_8_26_1","unstructured":"FlockhartD.Drug interactions: cytochrome P450 drug interaction table.Indiana University School of Medicine; 20072012."},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb04134.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(96)83095-1"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1998)7:1 <24::AID-DA7>3.0.CO;2-F"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122010159"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.v02n0602"},{"issue":"3","key":"e_1_2_8_32_1","first-page":"14","article-title":"Fluoxetine: clinical pharmacology and physiologic disposition","volume":"46","author":"Lemberger L","year":"1985","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199406003-00003"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199700321-00003"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199206000-00004"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199612005-00005"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-105443"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3283588fe5"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005280297"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0194"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(03)00041-1"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.25.1.119.55630"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1998.0419"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A136"},{"key":"e_1_2_8_45_1","article-title":"Dose\u2010dependent bradycardia with citalopram in an elderly patient","volume":"12","author":"Padala KP","year":"2010","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009340417"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.136"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199810000-00005"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2001.01328.x"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050615"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2009.02.006"},{"key":"e_1_2_8_52_1","unstructured":"DeanL.Metoprolol therapy and CYP2D6 genotype2017."},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.147"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.50"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S109054"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629080-00009"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K240"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528120-00007"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2009.tb02387.x"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1197\/jamia.M1809"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2011.583916"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1800"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.4422","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.4422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T16:17:53Z","timestamp":1695485873000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.4422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,24]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1002\/pds.4422"],"URL":"https:\/\/doi.org\/10.1002\/pds.4422","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,24]]},"assertion":[{"value":"2017-11-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}